Prospective Health Assessment of Cataract Patients' Ocular Surface
NCT ID: NCT01016405
Last Updated: 2011-02-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2009-06-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Assess the Clinical Outcomes of Surgical Phaco Segmentation Techniques in Patients Undergoing Cataract Surgery
NCT02843594
IOP Changes Associated With SICS and Phako
NCT02642211
Combined Cataract Surgery and Planned Descemetorhexis
NCT02206594
Analysis of Cataract Surgery Induced Dry Eye
NCT01471561
Evaluation of Meibomian Gland Dysfunction Before and After Cataract Surgery
NCT03276182
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Severity of dry eye in patients undergoing cataract surgery
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients must be scheduled to undergo cataract surgery.
Exclusion Criteria
* No previous Corneal laser vision correction in either eye within the last one year.
* No previous lid surgery within the past 3 months.
* Patients may not have used topical antibiotics, topical NSAIDs or topical steroid in either eye in the past month.
* Patients are not eligible if they have recently been started on Restasis solely as a perioperative treatment regimen.
* Patients presently using Restasis in either eye will not undergo any of the study testing but a questionnaire should be completed for these patients regarding use of these medications.
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovative Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Center for Excellence in Eye Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Trattler, MD
Role: PRINCIPAL_INVESTIGATOR
The Center for Excellence in Eye Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Center for Excellence in Eye Care
Miami, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0167
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.